1SB
EW icon

1ST Source Bank’s Edwards Lifesciences EW Stock Holding History

1ST Source Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$820K Buy
10,241
+47
+0.5% +$3.88K 0.04% 166
2025
Q4 		$869K Hold
10,194
– – 0.05% 152
2025
Q3 		$793K Sell
10,194
-13
-0.1% -$1.02K 0.04% 160
2025
Q2 		$798K Sell
10,207
-213
-2% -$15.9K 0.04% 154
2025
Q1 		$755K Hold
10,420
– – 0.04% 157
2024
Q4 		$771K Sell
10,420
-118
-1% -$8.26K 0.04% 157
2024
Q3 		$695K Hold
10,538
– – 0.04% 163
2024
Q2 		$973K Hold
10,538
– – 0.06% 130
2024
Q1 		$1.01M Buy
10,538
+11
+0.1% +$924 0.06% 136
2023
Q4 		$803K Sell
10,527
-750
-7% -$52.2K 0.05% 146
2023
Q3 		$781K Hold
11,277
– – 0.05% 139
2023
Q2 		$1.06M Sell
11,277
-149
-1% -$12.9K 0.07% 123
2023
Q1 		$945K Hold
11,426
– – 0.06% 131
2022
Q4 		$852K Sell
11,426
-191
-2% -$14.7K 0.06% 141
2022
Q3 		$960K Sell
11,617
-36
-0.3% -$3.46K 0.07% 129
2022
Q2 		$1.11M Buy
11,653
+41
+0.4% +$4.24K 0.08% 124
2022
Q1 		$1.37M Buy
11,612
+74
+0.6% +$8.3K 0.08% 115
2021
Q4 		$1.5M Buy
11,538
+36
+0.3% +$4.2K 0.09% 112
2021
Q3 		$1.3M Sell
11,502
-156
-1% -$17.8K 0.08% 118
2021
Q2 		$1.21M Hold
11,658
– – 0.08% 122
2021
Q1 		$975K Hold
11,658
– – 0.06% 131
2020
Q4 		$1.06M Sell
11,658
-522
-4% -$43.3K 0.08% 124
2020
Q3 		$972K Sell
12,180
-3,840
-24% -$300K 0.08% 118
2020
Q2 		$1.11M Buy
16,020
+3,759
+31% +$267K 0.1% 111
2020
Q1 		$771K Hold
12,261
– – 0.08% 119
2019
Q4 		$953K Sell
12,261
-60
-0.5% -$4.68K 0.07% 120
2019
Q3 		$903K Sell
12,321
-1,386
-10% -$97.4K 0.07% 121
2019
Q2 		$844K Sell
13,707
-594
-4% -$35.9K 0.07% 121
2019
Q1 		$912K Sell
14,301
-51
-0.4% -$2.91K 0.08% 115
2018
Q4 		$733K Sell
14,352
-450
-3% -$22.8K 0.07% 115
2018
Q3 		$859K Buy
14,802
+369
+3% +$18K 0.07% 121
2018
Q2 		$700K Sell
14,433
-135
-0.9% -$6.3K 0.06% 129
2018
Q1 		$678K Sell
14,568
-333
-2% -$14.5K 0.06% 137
2017
Q4 		$560K Sell
14,901
-186
-1% -$6.83K 0.05% 147
2017
Q3 		$550K Sell
15,087
-42
-0.3% -$1.6K 0.05% 147
2017
Q2 		$596K Sell
15,129
-3
-0% -$110 0.05% 144
2017
Q1 		$474K Buy
15,132
+3,378
+29% +$106K 0.04% 159
2016
Q4 		$367K Buy
11,754
+24
+0.2% +$778 0.03% 172
2016
Q3 		$471K Hold
11,730
– – 0.05% 158
2016
Q2 		$390K Buy
11,730
+750
+7% +$25.7K 0.04% 166
2016
Q1 		$323K Hold
10,980
– – 0.04% 173
2015
Q4 		$289K Sell
10,980
-16,920
-61% -$439K 0.03% 184
2015
Q3 		$661K Buy
27,900
+17,820
+177% +$430K 0.08% 150
2015
Q2 		$239K Hold
10,080
– – 0.03% 228
2015
Q1 		$239K Hold
10,080
– – 0.03% 197
2014
Q4 		$214K Buy
+10,080
New +$203K 0.03% 210

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

1ST Source Bank's EW Position: Q1 2026 in Review

1ST Source Bank increased its Edwards Lifesciences (EW) stake by 0.46% in Q1 2026, buying an estimated $3.88K and bringing the position to 10,241 shares worth $820K. The position accounts for 0.04% of the portfolio, ranked #166.

1ST Source Bank first reported a position in EW in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.5M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • 1ST Source Bank held 10,241 shares of Edwards Lifesciences worth $820K as of Q1 2026.
  • 1ST Source Bank bought 47 Edwards Lifesciences shares in Q1 2026, an estimated $3.88K.
  • Edwards Lifesciences made up 0.04% of 1ST Source Bank's portfolio in Q1 2026, its #166 holding.
  • 1ST Source Bank first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 46 quarters since.
  • 1ST Source Bank's Edwards Lifesciences position peaked at $1.5M in Q4 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on 1ST Source Bank's 13F filing for Q1 2026, filed 4 May 2026.